{
  "id": 18075676,
  "title": "Emcure Pharma shares hit 10% upper circuit after FY27 guidance hike; Jefferies raises target price by 8%",
  "url": "https://urgent.news/2026/11/04/emcure-pharma-shares-hit-10-upper-circuit-after-fy27-guidance-hike",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-04T04:31:03.000Z",
  "source": {
    "name": "The Economic Times - Top News",
    "slug": "the-economic-times-top-news",
    "url": "https://economictimes.indiatimes.com/markets/stocks/news/emcure-pharma-shares-hit-10-upper-circuit-after-fy27-guidance-hike-jefferies-raises-target-price-by-8/articleshow/135523159.cms"
  },
  "original_language": "en",
  "account": null,
  "summary": "Emcure Pharma shares hit a 10% upper circuit after strong Q2 FY27 results prompted the company to raise its full-year growth guidance. Brokerages turned more positive, citing robust international business, improving domestic growth and a strong product pipeline.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}